The National Institute of Allergy and Infectious Diseases has started a series of clinical trials on humans to examine a potential vaccine candidate NIAID hopes can help counter the Zika virus. NIAID started
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.